
Biotechnology
Innovations in cancer immunotherapy: Bi-specific T cell engagers
Bi-specific T cell engagers are poised to become key immunotherapy treatments due to simpler production and new safety advances.
Lea el informeLeer el artículoDescargar el resumenVer la infografíaLea la publicaciónLeer el resumenVer el vídeo






















